Form 13-F position report

* INTEGRA LIFESCIENCES HLDGS

Reported by COOKE & BIELER LP

IART CUSIP 457985208 Manager CIK 0000024386

Reported 2,834,604 shares, up 120,410 (4.4%) from the prior quarter.

Reported value 19.1%; share count 4.4% vs. the prior quarter.

Added
% of reported 13F value 1.09% This manager · Q4 2023
Shares 2,834,604 Quarter-end amount reported
Reported value $123,447,004 Fair value at quarter end
Consecutive quarters held 17 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 159244000
2022-03-31 162540000
2022-06-30 134717000
2022-09-30 115764000
2022-12-31 153186941
2023-03-31 152743381
2023-06-30 112681969
2023-09-30 103655069
2023-12-31 123447004
2024-03-31 110801492
2024-06-30 102406148
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

12 quarters
Quarterly reported position history for * INTEGRA LIFESCIENCES HLDGS held by COOKE & BIELER LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -3,514,281 (-100.0%) 0 $0 2024-11-08
Q2 2024 Added 3,514,281 +388,710 (12.4%) 0.99% $102,406,148 2024-08-02
Q1 2024 Added 3,125,571 +290,967 (10.3%) 1.02% $110,801,492 2024-05-10
Q4 2023 Added 2,834,604 +120,410 (4.4%) 1.09% $123,447,004 2024-01-31
Q3 2023 Reduced 2,714,194 -25,460 (-0.9%) 1.01% $103,655,069 2023-11-14
Q2 2023 Added 2,739,654 +79,083 (3.0%) 1.05% $112,681,969 2023-07-31
Q1 2023 Reduced 2,660,571 -71,495 (-2.6%) 1.49% $152,743,381 2023-05-08
Q4 2022 Reduced 2,732,066 -793 (0.0%) 1.5% $153,186,941 2023-02-08
Q3 2022 Added 2,732,859 +239,485 (9.6%) 1.24% $115,764,000 2022-11-15
Q2 2022 Reduced 2,493,374 -36,045 (-1.4%) 1.3% $134,717,000 2022-07-20
Q1 2022 Added 2,529,419 +152,293 (6.4%) 1.43% $162,540,000 2022-05-09
Q4 2021 Reduced 2,377,126 -4,480 (-0.2%) 1.37% $159,244,000 2022-02-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

310 managers reported * INTEGRA LIFESCIENCES HLDGS for Q4 2023.

Managers reporting * INTEGRA LIFESCIENCES HLDGS in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 7,012,793 -147,061 < 0.01% $305,407,135 43 qtrs
BlackRock Inc Reduced 6,641,845 -192,342 < 0.01% $289,252,352 43 qtrs
MORGAN STANLEY Reduced 5,270,697 -677,945 0.02% $229,538,956 43 qtrs
Capital Research Global Investors Added 4,297,326 +1,228,996 0.05% $187,148,547 31 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 3,185,293 +151,344 0.03% $138,719,511 29 qtrs
COOKE & BIELER LP This report Added 2,834,604 +120,410 1.09% $123,447,004 17 qtrs
ALLIANCEBERNSTEIN L P Reduced 2,725,502 -67,329 0.05% $118,695,612 43 qtrs
Clearbridge Investments LLC Reduced 2,474,249 -267,673 0.09% $107,753,562 43 qtrs
Champlain Investment Partners LLC Reduced 2,435,957 -2,872 0.63% $106,085,927 43 qtrs
STATE STREET CORPORATION Reduced 2,115,767 -21,794 < 0.01% $92,141,653 43 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
January 31, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,231,928
Shared
0
None
602,676

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.